Trader: Low Volume ...
A.P. Pharma Inc. (APPA: OTC)
$0.58 0.00 | 0.00%
06/04/12 - 10:32 AM ET
Company Cash Flow
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -11.81M | -7.35M | -10.03M | -23.12M |
| Operating Gains/Losses | 0.00 | 4.00K | 17.00K | 85.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 110.00K | 61.00K | -139.00K | 100.00K |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 467.00K | -3.00K | -182.00K | -1.09M |
| (Decrease) Increase In Other Current Liabilities | 1.30M | -579.00K | -1.80M | -2.29M |
| (Increase) Decrease In Other Working Capital | -349.00K | -13.00K | -25.00K | -28.00K |
| Other Non-Cash Items | 2.27M | 1.90M | 1.10M | 1.31M |
| Net Cash From Continuing Operations | -7.72M | -5.48M | -11.00M | -24.29M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 19.00K |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -7.72M | -5.48M | -11.00M | -24.28M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 614.00K | 976.00K |
| Purchases of Property, Plant & Equipment | -513.00K | -78.00K | -2.00K | -298.00K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -513.00K | -78.00K | 612.00K | 678.00K |
| Issuance of Debt | 1.31M | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 22.79M | 77.00K | 8.01M | 54.00K |
| Repayment of Long-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | 24.10M | 77.00K | 8.01M | 54.00K |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 15.86M | -5.48M | -2.37M | -23.54M |
Portfolios with APPA
- Portfolio NameUser Type
- UserMy Folio
- Userwatchlist1
- UserMARK 1 C
- ContributorBarron's Insider Purchases ...
- UserSUPRATRADE-2709091838
- UserLatest Activist Filings 2-2...
- ContributorBarron's Insider Purchases ...
- ContributorBarron's Insider Purchases ...
- ContributorBarron's Insider Purchases ...
- UserBarron's Insider Purchases ...
Latest APPA Headlines from TheStreet
- Ambac Financial, QAD: Early Volume Plays 05.18.10 | 08:05 am
- A.P. Pharma, Netlist: Early Volume Plays 03.19.10 | 10:03 am
- Biotech Stock Mailbag: Sequenom 03.12.10 | 07:03 am
- Latest News in Activist Investing 02.26.09 | 11:02 am
- Insider Action: Trading Level 3 10.03.08 | 12:10 pm
- Monday's Small-Cap Winners & Losers 06.25.07 | 04:06 pm
- Thursday's Health Winners & Losers 12.21.06 | 01:12 pm
- Monday's Small-Cap Winners & Losers 10.02.06 | 03:10 pm
Press Releases for APPA
- A.P. Pharma Announces Study Finding Continuous Exposure To A 5-HT3 Antagonist Using APF530 Provides Better Emetic Control - Business Wire 05.31.12 | 08:05 am
- A.P. Pharma Announces First Quarter 2012 Financial Results And Recent Corporate Progress - Business Wire 05.10.12 | 08:05 am
- A.P. Pharma Announces Third Quarter 2011 Financial Results And Recent Corporate Progress - Business Wire 11.07.11 | 08:11 am
- LifeSci Advisors Announces Investment Opinion On A.P. Pharma Inc. - Business Wire 08.29.11 | 01:08 pm
- A.P. Pharma Announces Second Quarter 2011 Financial Results And Reports On Recent Corporate Progress - Business Wire 08.08.11 | 08:08 am
- A.P. Pharma To Raise $24 Million In Private Placement Of Common Stock And Warrants - Business Wire 06.29.11 | 08:06 am
- A.P. Pharma Announces First Quarter 2011 Financial Results And Recent Corporate Progress - Business Wire 05.16.11 | 08:05 am
- A.P. Pharma Announces Financing Of Up To $4.5 Million And Names CEO And COO - Business Wire 04.25.11 | 08:04 am
- A.P. Pharma Provides Regulatory Update On APF530 NDA - Business Wire 04.25.11 | 08:04 am
- A.P. Pharma Announces Transfer To OTCQB - Business Wire 03.31.11 | 06:03 am
Partner Headlines for APPA
- Mannkind Slashes Staff: Biotech's Latest Tribulations - Seeking Alpha 02.13.11 | 08:02 am
- UPDATE 3-FDA denies approval of AP Pharma nausea drug; shrs sink - Reuters 03.19.10 | 12:03 pm





